16 employees
Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.
2022
$122M
from 3 investors over 3 rounds
IDRx raised $122M on August 2, 2022
Investors: Casdin Capital, LLC, Andreessen Horowitz and Nextech Invest